Non-HLA Antibodies and Their Role in Highly Sensitized Patients.

[1]  K. Oh,et al.  Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection , 2022, Transplant International.

[2]  E. Reed,et al.  Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection , 2021, Frontiers in Immunology.

[3]  N. Reinsmoen.  Compelling scientific and clinical evidence that non-HLA specific antibodies impact graft outcome independently and in concert with donor HLA specific antibodies. , 2019, Human immunology.

[4]  D. San Segundo,et al.  Anti-perlecan antibodies and acute humoral rejection in hypersensitized patients without forbidden HLA specificities after kidney transplantation. , 2019, Transplant immunology.

[5]  E. Lerut,et al.  Histological picture of antibody‐mediated rejection without donor‐specific anti‐HLA antibodies: Clinical presentation and implications for outcome , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  R. Montgomery,et al.  Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested? , 2018, Human immunology.

[7]  P. Nickerson,et al.  Pre-transplant AT1R antibodies correlate with early allograft rejection. , 2017, Transplant immunology.

[8]  E. Cozzi,et al.  The mechanisms of rejection in solid organ transplantation. , 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[9]  D. San Segundo,et al.  Improvement in the definition of anti-HLA antibody profile in highly sensitized patients , 2017, PloS one.

[10]  D. San Segundo,et al.  Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies? , 2016, Transplantation proceedings.

[11]  R. Matesanz,et al.  Implementation of a National Priority Allocation System for Hypersensitized Patients in Spain, Based on Virtual Crossmatch: Initial Results. , 2016, Transplantation proceedings.

[12]  J. Lunz,et al.  EDTA Treatment of Serum Unmasks Complement-Mediated Prozone Inhibition in Human Leukocyte Antigen Antibody Testing. , 2016, American journal of clinical pathology.

[13]  A. Jackson,et al.  Non-HLA antibodies in transplantation: when do they matter? , 2016, Current opinion in organ transplantation.

[14]  E. Reed,et al.  The importance of non-HLA antibodies in transplantation , 2016, Nature Reviews Nephrology.

[15]  Josef Stehlik,et al.  The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  E. Paz-Artal,et al.  Harmful Effect of Preformed Anti-MICA Antibodies on Renal Allograft Evolution in Early Posttransplantation Period , 2013, Transplantation.

[17]  A. Matas,et al.  Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  M. J. Acevedo,et al.  Antibodies against heterogeneous nuclear ribonucleoprotein K in patients with cardiac allograft vasculopathy. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  J. Cecka.  Calculated PRA (CPRA): The New Measure of Sensitization for Transplant Candidates , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  N. Reinsmoen.  Immunological Risk Stratification by Assessing Both the HLA and Non-HLA-Specific Antibodies: Time to Include Testing for Non-HLA Antibodies in the Routine Clinical Antibody Analysis Profile? , 2017, Transplantation.